Saturday, June 27, 2026

HomeHealth NewsBeyond GLP-1s: The next chapter of obesity care

Beyond GLP-1s: The next chapter of obesity care

- Advertisement -

The figure provides a comprehensive, multidisciplinary process to guide and personalize innovative obesity care. Credit: Gastroenterology

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation’s most pressing chronic diseases.

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed